A B S T R A C T These studies were designed to determine whether pteroylmonoglutamic acid (PGA) at physiologic concentrations is transported across the small intestine unaltered or is reduced and methylated to the circulating folate form (5-methyltetrahydrofolate PGA concentration: at 7, 20, and 2,000 nM, 44%, 34%, and 2%, respectively, was converted to 5-AMeFH4. In contrast, less than 4% of the folate transferred across ileal mucosa was 5-MeFH4 when the initial mucosa concentration was 20 nM. Specific activity of dihydrofolate (DHF) reductase, the enzyme responsible for converting PGA to tetrahydrofolic acid, was measured in villus homogenates and was significantly greater in the jejunum than in the ileum. 1,000 nM methotrexate (MTX), a DHF reductase inhibitor, markedly inhibited PGA conversion to 5-MeFH4 by the jejunum.
INTRODUCTION
MIost studies of intestinal folate absorption in man and animals (1) (2) (3) (4) (5) (6) (7) (8) have centered around pteroylmonoglutamic acid (PGA)' which is stable and readily available. Less than 10%, , of dietary folate, however, is PGA (9) . In the diet folate is found predominantly as polyglutamates of several reduced folate compounds, primarily 5-methyltetrahydrofolic acid (5-MeFH4) (9) (10) (11) .
Despite much study, there is still disagreement over the mechanism of PGA absorption (12) . Whether PGA is absorbed preferentially in the jejunum or in the ileum, whether it is absorbed by active transport or by diffusion, whether it is transferred across the intestinal mucosa intact or converted to other folate forms during its transfer, and whether it is utilized by the intestine with or without conversion to reduced and methylated compounds remain unknown. Recently developed chromatographic methods which permit identification of folate compounds have been utilized in this study to determine whether at physiologic concentrations PGA is 1Abbreviations used in this paper: DHF, dihydrofolate; FH4 tetrahydrofolic acid; 5-MeFH4, 5-methyltetrahydrofolic acid; MTX, methotrexate; pABG, p-aminobenzoylglutamate; PGA, pteroylmonoglutamate or folic acid; TK, thymidine kinase. Folate is used to refer to all folate compounds, both reduced and nonreduced.
converted to other folate forms during its transfer across the rat intestinal mucosa. Identification of folate compounds by chromatography (13) Samples were desalted by chromatography through a Sephadex G-15 Column equilibrated with 0.1 M mercaptoethanol and eluted by the same solvent. Fractions which contained radioactivity or folate markers were pooled and applied to a 0.9 x 27 cm column of A-25 DEAE Sephadex equilibrated with 0.1 M phosphate buffer, pH 6.0, containing 20 mM mercaptoethanol. Materials were eluted by phosphate buffer, pH 6.0, the concentration of which was increased linearly from 0.1 to 2.0 M also containing 20 mM mercaptoethanol. The final concentration of 2.0 M phosphate buffer was obtained after passage of 500 ml of eluting buffer. Nonradioactive markers of 5-MeFH4, PGA, 5-10 methylene FH4, and paraminobenzoic acid (pABG) were added with the sample when applicable. Fractions of 2.5 ml were collected and monitored by radioactivity and by ultraviolet absorbance spectra.
METHODS

Materials
This system separates monoglutamate folate forms reasonably well; there was some overlap between the 5-10 methylene FH4 peaks and 5-MeFH4, but the peak tubes of these compounds were separable (13) . Good separation between 5-MeFH4 and PGA and 5-10 methenyl FH4 was achieved with only slight overlap between peaks. Quantitation of various folate forms was accomplished by manual integration, correcting for overlap where necessary.
The tritiated PGA was purified by column chromatography first on A-25 DEAE-Sephadex, then on Sephadex G-25 and, when utilized, was greater than 99% radiochemically pure.
Transport studies
Nonfasting male Sprague-Dawley rats weighing 300-350 g were used in all experiments. Intestinal folate transport was studied by several in vitro techniques: mucosal influx (14) and uptake (15) and unidirectional transmural movement (16 H2PO4, 0.4 mM; HPO4, 2.4 mM; Mg, 1.2 mM; Ca, 1.2 mM; K, 5.2 mM, and ascorbic acid, 10 mM. The pH was maintained at 7.4. After a 20 min incubation period, the rate of appearance of the radiolabeled material in the serosal solution was determined for four 20 min periods. Samples (1 ml) were added to Bray's solution and were counted in a liquid scintillation spectrometer. In these studies results wvere expressed as picomoles of folate transferred to the serosal solution per square centimeter of tissue per hour. At the conclusion of the 100 min experimental period, appropriate mucosal and serosal bathing solutions from two to three experiments were pooled and stored overnight in 3 M mercaptoethanol at 4°C. Identification of the folate transferred to the serosal side was then determined by column chromatography (vide sutpra). Compounds identified were quantitated in terms of picomoles transferred to the serosal solution per square centimeter per hour by combining the relative proportion of each compound transferred as determined by the chromatographic analysis with the total mucosal to serosal folate transfer. The relative proportion of each compound was calculated by expressing the amount of the folate isolated over the total folate recovered on chromatography as a percentage.
Mucosal infltux and uptake of folate were determined by modification of the tissue accumulation method (15) . Short (1-2 cm, 100-150 mg), everted segments of jejunum and ileum filled with a Ringer buffer were placed in flasks containing 20 nM PGA with and without 1,000 nM MTX. The flasks were continuously oxygenated during incubation periods which varied from 0.6 to 60 min. At the end of the incubation, the tissue was removed, washed in 0.3 M mannitol, drained, blotted, weighed, and placed in boiling water for 5 min. Aliquots of the boiling water extract and the mucosal incubation media were obtained for liquid scintillation counting. The tissue was dried at 110°C overnight and weighed. Inulin space was determined in separate experiments at all incubation periods and experimental conditions and utilized to correct for the extracellular space. The results were expressed as picomoles of folate accumulated per hour per milligram dry tissue weight.
Tissue uptake represents the accumulation of folate under steady-state conditions. After preliminary studies demonstrated that tissue accumulation had reached equilibrium by 30 min, a 40 min incubation period was employed for determination of mucosal uptake. Mucosal influx measures the initial rate of entry of a substance from the external media to the mucosal cell and must be determined during a period of time when mucosal accumulation is linear with respect to time. Therefore, shorter incubation periods are required to determine mucosal influx than are required for mucosal uptake determinations. In additional preliminary experiments, mucosal accumulation was observed to be linear during incubation periods up to two minutes. Therefore, 1 min incubation periods were employed for determination of mucosal influx.
Intestinal enzyme analyses
In another series of experiments, homogenates of both the total mucosa and relatively pure villi were obtained, and dihydrofolate (DHF) reductase, thymidine kinase (TK), and sucrase activities were assayed. In these studies, the small intestine was removed, placed in cold 5 x 10' M Tris buffer with 10-' M thymidine, pH 7.5 (tris-thymidine buffer). The small intestine was divided into three equal parts of approximately 30 cm in length after flushing with the tris-thymidine buffer. The middle segment was dis- carded and the proximal and distal segments were used as jejunal and ileal segments, respectively. Each segment was lightly scraped along the mucosa as described by Dietschy and Siperstein (18) to separate the intestinal villi from the remaining mucosal and muscular layers. This preparation is hereafter referred to as the villus preparation. Additional tissue underwent a more forceful scraping to separate total mucosa from the underlying smooth muscle layer and is referred to as the total mucosal preparation. Histologic evaluation of these intestinal layers were determined on formalin-fixed, hematoxylin-and eosin-stained sections of each preparation. The jejunal and ileal villi and the total mucosal fraction were individually homogenized for 1-2 min. The homogenates were centrifuged for 15 min at 27,000 g and the supernatant fluid from each homogenate was divided into three equal aliquots. One aliquot was used for immediate determination of TK activity, and the other two were stored at -70°until used for determination of DHF reductase activity, sucrase activity, and protein content. Thymidine kinase activity was determined using the assay of Chello and Jaffe (19) and the chromatographic separation of Furlong (20) . The (Table I) .
The conversion of PGA to 5-MeFH4 involves initial reduction of PGA to FH4 (24) . Methotrexate (MTX), a DHF reductase inhibitor, prevents the conversion of PGA to FH4. Therefore, another series of experiments were performed in which 20 nM PGA was present on the mtucosal side of the jejunum with 1,000 nM MITX (Table II) . IUnder these conditions, the percent of folate in the serosal solution appearing as 5-MeFH4 was markedly reduced. In the presence of MITX, 6% of the folate appearing in the serosal solution was 5-MeFH4; however, the total transmural folate movement was significantly increased. Therefore, the amount of PGA transferred across the jejunum in the presence of MTX increased.
Studies to compare PGA transfer at a 20 nM mucosal concentration in the ileum with that in the jejunum 2140 E. J. Olinger, J. R. Bertino, and H. J. Binder to determine net mucosal uptake. In these studies (Table  III) , mucosal uptake in the jejunum is significantly inhibited by the presence of MTX. Jejunal uptake was 70.3±5.4 pmol/h per mg dry tissue weight and in the presence of MTX jejunal uptake was 49.3±2.9 pmol/h per mg dry tissue weight. Jejunal uptake is also greater than ileal uptake. DHF reductase activity. DHF reductase specific activity was determined in both the total mucosal and villus preparations. Table IV demonstrates that DHF reductase specific activity was slightly but not significantly greater in the jejunal than in the ileal total mucosal preparation. The total mucosal preparation, however, contains both villus and crypt epithelial cells. Therefore, DHF reductase activity was also determined in a relatively pure villus preparation since the crypt cells probably contain significant amounts of DHF reductase and are not normally involved with absorption. In contrast to the DHF reductase activity in the total mucosal preparation, DHF reductase specific activity was significantly greater in the supernatant fraction of jejunal villi compared to that of ileal villi. (32) (33) (34) .
Coh0en, usiing a (lifferential microbiological assay, suggestedl that part of the PGA that crosses the hamster sm11all in1testinie was converted to 5-MIeFH4 (35) . It is notable that Cohen used anl initial mucosal concentratioln of approximately 25 nM. Partial conversion of PGA to 5-\IeFH4 by rat jejunutmii hals also been reporte(d (36) . Smllith, Mattv, and Blair in studlies of everted intestinal sacs from rats eniiployed 10' and 10-M PGA in their mlucosal incubationi and reported "a nminor radioactive component" wN-ith their chromatographic assay system wvhich co-chromatographed with both 5-formvl FH4 and 5-MeFH4 markers (8) .
Our studies result in several con1clusions. The rat jej'unumi conxverts I'GA to 5-iMeFH,. Tlherefore, PGA mav be transferred across the jejunal mucosa in at least two forms: unaltered PGA and PGA converted to 5-MeFH4; reduction is not essential to the absorption of PGA. At low mucosal PGA concentrations, however, the conversion of PGA to 5-MIeFH4 is qualitatively more inmportant than at highler mucosal PGA concentrations. At higlher mucosal PGA concentrations the amount appearing on the serosal side as 5-MeFH4 increases, but the percent appearing as 5-MeFH4 decreases, an ob-servation which suggests that the conversion of 5-MeFH4 is a saturable process. These results may explain conflicting observations on the production of 5-MeFH4 by the intestinal mucosa during absorption of PGA. WThat is found in the serosal solution or in the peripheral blood depends upon the PGA concentration in the mucosal incubation media, the surface area and time available for absorption, the quantity of folate in the sample to be analyzed, and the sensitivity of the assay method used to identify the various folate analogues. With higher mucosal concentrations of PGA, 5-MeFH4 may not be identified, even though significant absolute quantities of 5-MeFH4 may be present. Conversely, 5-MeFH4 will be more readily identified when the percent of PGA converted to 5-MeFH4 is greater; a phenomenon observed at low initial mucosal PGA concentrations. Indeed, in those studies which have not demonstrated 5-MeFH4 a relatively high initial PGA concentration was employed. Our studies readily demonstrated conversion to 5-MeFH4 when 7 or 20 nMI PGA was used, but when a high PGA concentration (2,000 nM) was present, minimal conversion was noted.
The conversion of PGA to 5-MeFH4 involves reduction of FH4 by DHF reductase and subsequent methvlation to 5-MeFH4 (24) . MITX, a DHF reductase inhibitor, markedly reduced the appearance of 5-MeFH4 in the serosal medium, presumably by inhibiting the first step of the process. Further, there is a correlation between the location of DHF reductase activity in the intestinal mucosa and the appearance of 5-MeFH4. DHF reductase specific activity is significantly greater in the jejunum than in the ileum, and the folate appearing on the serosal side as 5-MIeFH4 is also significantly greater in the jejunum than in the ileum.
DHF reductase activity was determined in the villus as well as in the total mucosal tissue preparation since the crypt region, an area of active DNA and protein synthesis, might contain significant amounts of DHF reductase and so mask differences in the specific activities between jejunal and ileal villi. The use of sucrase and thymidine kinase as enzyme markers to verify the purity of the villus preparation is based on the work of Fortin-Magana, Hurwitz, Herbst, and Kretchmer (37) who demonstrated that greater sucrase activity was present in villi of the rat intestine than in crypt preparations and greater thymidine kinase activity in crypt preparations than in villi. Measurement of these enzyme activities in our preparations also indicated that the villus preparation contained mainly villi, not crypt epithelium (Fig. 2 ).
An unexpected finding was that the total folate transferred across the jejunum incubated in the presence of MTX and across the ileum was greater than the total folate transferred across the jejunum in the absence of MTX. One explanation of these results (Table II) Goldman has observed just such a phenomenon involving several folate analogs including MTX (38, 39) .
Although at present this explanation cannot be completely excluded, there has been little evidence to date to indicate the existence of carrier mediated folate transfer in the intestine. Our previous unexplained observation that 5-formyl FH4 increases 5-MeFH4 transfer, however, is compatible with this counter transport model (17) . Additional experiments are required to test this hypothesis.
The results of studies comparing jejunal and ileal transport can also be explained by retention of the newly formed 5-MeFH4 by the jejunal mucosa. In the jejunum, both mucosal influx and uptake is greater than ileal mucosal influx and uptake, although transmural folate is greater in the ileum than in the jejunum. This suiggests that in the jejunum muclh of the PGA that enters the mucosa is converted to 5-MIeFH4 and remains in the mucosa. In the ileum the greater transmural folate flux associated with a smaller mucosal uptake sug-ests that little of the PGA entering the mucosa is converted to 5-MeFH4 and that PGA is not retained. concentrations of PGA comparable to that present in the diet, the intestine nmay be the primary site of PGA redluction and methylation and production of 5-MeFH4.
